Great news for Artemisia annua and our Artennua® product. A new article (Desrosiers et al., 2020) published by the BIOMOLECULES journal and conducted by researchers at the Worcester Polytechnic Institute, USA, suggests interesting results on the bioavailability of artemisinin available between Artemisia annua plant in comparison with semi-synthetic artemisinin molecule. For the study, human liver…
Artennua is an optimized version of Artemisia annua, a medicinal plant used for centuries in Chinese Medicine that is the only natural source of Artemisinin. Artemisinin is the molecule recommended by the WHO to treat malaria.
Artemisinin, its derivatives, and other secondary metabolites contained in the plant Artemisia annua, have the potential to treat a broad range of diseases and afflictions. However, Artemisia annua produces very low quantities of artemisinin and thus its global supply is limited.
As scientists and social entrepreneurs, we have used natural plant biopharming methods to improve some characteristics of the Artemisia annua plant meaning its therapeutic properties can now be exploited more extensively.